Page 9 - Nasdaq Ispc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq ispc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Ispc Today - Breaking & Trending Today

iSpecimen (ISPC) and The Competition Financial Comparison

ISpecimen (NASDAQ:ISPC – Get Rating) is one of 44 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its competitors? We will compare iSpecimen to related companies based on the strength of its valuation, institutional ownership, risk, analyst recommendations, profitability, earnings and dividends. Valuation & Earnings This table […] ....

United States , Specimen Company Profile , Specimen Inc , Get Rating , Specimen Company , Specimen Marketplace , Specimen Daily , Nasdaq Ispc , Stock Comparison , Stock Analysis ,

iSpecimen Inc. (NASDAQ:ISPC) Short Interest Down 45.2% in May

ISpecimen Inc. (NASDAQ:ISPC – Get Rating) saw a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 86,200 shares, a drop of 45.2% from the May 15th total of 157,400 shares. Currently, 1.6% of the company’s stock are short sold. Based on an average daily […] ....

Geode Capital Management , Grimes Company Inc , Blackrock Inc , Teton Advisors Inc , Specimen Inc , Get Rating , Street Group , Nasdaq Ispc ,

Reviewing iSpecimen (NASDAQ:ISPC) & ICON Public (NASDAQ:ICLR)

ISpecimen (NASDAQ:ISPC – Get Rating) and ICON Public (NASDAQ:ICLR – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Institutional and Insider Ownership 30.9% of iSpecimen shares are held by […] ....

United States , Specimen Company Profile Get Rating , Public Company Profile Get Rating , Public Limited Company , Specimen Inc , Get Rating , Specimen Company Profile , Specimen Marketplace , Company Profile , Limited Company , Nasdaq Ispc , Stock Comparison , Stock Analysis ,

Reviewing iSpecimen (NASDAQ:ISPC) and National Research (NASDAQ:NRC)

ISpecimen (NASDAQ:ISPC – Get Rating) and National Research (NASDAQ:NRC – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership. Valuation & Earnings This table compares iSpecimen and National Research’s […] ....

United States , Michaeld Hays , Specimen Company Profile Get Rating , National Research Corp , National Research Company Profile Get Rating , Specimen Inc , National Research , Get Rating , Specimen Company Profile , Specimen Marketplace , Research Company Profile , Nasdaq Ispc , Stock Comparison , Stock Analysis ,